According to the American Diabetes Association (ADA) Standards of Care in Diabetes, “glutamic acid decarboxylase (GAD) autoantibody should be measured and, if negative, should be followed by islet tyrosine phosphatase 2 (IA-2) and/or zinc transporter 8 (ZnT8)”, when available [7]. Here, PTPRN is linked to diabetes mellitus.